000 | 01415 a2200373 4500 | ||
---|---|---|---|
005 | 20250516081841.0 | ||
264 | 0 | _c20120628 | |
008 | 201206s 0 0 eng d | ||
022 | _a0972-2823 | ||
024 | 7 |
_a10.4103/0022-3859.93244 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRayhill, M L | |
245 | 0 | 0 |
_aGabapentin use in the prevention of succinylcholine-induced fasciculation and myalgia. _h[electronic resource] |
260 |
_bJournal of postgraduate medicine _c |
||
300 |
_a1-2 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 |
_aAmines _xadministration & dosage |
650 | 0 | 4 |
_aAnalgesics _xadministration & dosage |
650 | 0 | 4 | _aCholecystectomy, Laparoscopic |
650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xadministration & dosage |
650 | 0 | 4 |
_aFasciculation _xprevention & control |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGabapentin |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeuromuscular Depolarizing Agents _xadverse effects |
650 | 0 | 4 |
_aNeuromuscular Diseases _xprevention & control |
650 | 0 | 4 |
_aPain, Postoperative _xprevention & control |
650 | 0 | 4 |
_aSuccinylcholine _xadverse effects |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xadministration & dosage |
700 | 1 | _aPerloff, M D | |
773 | 0 |
_tJournal of postgraduate medicine _gvol. 58 _gno. 1 _gp. 1-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4103/0022-3859.93244 _zAvailable from publisher's website |
999 |
_c21594489 _d21594489 |